Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Novel protein kinase inhibitors synthesized at Bayer Schering Pharma

July 19, 2012

Researchers at Boehringer Ingelheim patent new CXCR2 receptor antagonists

July 19, 2012

Abbott designs new potential hepatitis therapies

July 18, 2012

Novel protein kinase inhibitors disclosed by Roche

July 18, 2012

German researchers present new GPR119 receptor agonists

July 18, 2012

Allergan patents new CCR2 receptor antagonists

July 18, 2012

Array BioPharma synthesizes novel kinase inhibitors

July 18, 2012

Novel TTK inhibitors patented by Bayer Schering Pharma

July 18, 2012

Janssen R&D Ireland presents new antiviral agents

July 17, 2012

Swiss researchers patent novel anti-SOD1 antibodies

July 17, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...